» Authors » Rebecca L Elstrom

Rebecca L Elstrom

Explore the profile of Rebecca L Elstrom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 2437
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghobadi A, Bachanova V, Patel K, Park J, Flinn I, Riedell P, et al.
Lancet . 2025 Jan; 405(10473):127-136. PMID: 39798981
Background: FT596 is an induced pluripotent stem-cell (iPSC)-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy with three antitumour modalities: a CD19 CAR; a high-affinity, non-cleavable CD16 Fc receptor;...
2.
Elstrom R, Schuster S
PET Clin . 2016 May; 7(1):xiii. PMID: 27157022
No abstract available.
3.
Wilson W, Young R, Schmitz R, Yang Y, Pittaluga S, Wright G, et al.
Nat Med . 2015 Jul; 21(8):922-6. PMID: 26193343
The two major subtypes of diffuse large B cell lymphoma (DLBCL)--activated B cell-like (ABC) and germinal center B cell-like (GCB)--arise by distinct mechanisms, with ABC selectively acquiring mutations that target...
4.
Bussel J, Lee C, Seery C, Imahiyerobo A, Thompson M, Catellier D, et al.
Haematologica . 2014 Apr; 99(7):1264-71. PMID: 24747949
Adults with newly diagnosed or persistent immunothrombocytopenia frequently relapse upon tapering steroids; adults and children with chronic disease have an even lower likelihood of lasting response. In adults with newly-diagnosed...
5.
Elstrom R, Ruan J, Christos P, Martin P, Lebovic D, Osborne J, et al.
Leuk Lymphoma . 2014 Apr; 56(2):342-6. PMID: 24730538
Radioimmunotherapy (RIT) is effective treatment for indolent non-Hodgkin lymphomas (NHLs), but response durations are usually limited, especially in aggressive NHL. We hypothesized that administration of bortezomib as a radiosensitizer with...
6.
Clozel T, Yang S, Elstrom R, Tam W, Martin P, Kormaksson M, et al.
Cancer Discov . 2013 Aug; 3(9):1002-19. PMID: 23955273
Unlabelled: Although aberrant DNA methylation patterning is a hallmark of cancer, the relevance of targeting DNA methyltransferases (DNMT) remains unclear for most tumors. In diffuse large B-cell lymphoma (DLBCL) we...
7.
Elstrom R
Leuk Lymphoma . 2012 Sep; 54(4):673-4. PMID: 22950372
No abstract available.
8.
Elstrom R
Leuk Lymphoma . 2012 Jun; 53(11):2095-6. PMID: 22680772
No abstract available.
9.
Coleman M, Ruan G, Elstrom R, Martin P, Leonard J
Hematology . 2012 Apr; 17 Suppl 1:S90-2. PMID: 22507790
Background: Metronomic therapy is the application of continuous, low dose chemotherapy. The doses of chemotherapy are usually not sufficient to destroy neoplastic cells, but impact the milieu, particularly angiogenesis. Objective:...
10.
Elstrom R, Martin P, Rua S, Shore T, Furman R, Ruan J, et al.
Am J Hematol . 2012 Feb; 87(4):433-5. PMID: 22367772
No abstract available.